Natural Product: NPC476858

Natural Product IDNPC476858
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
ethyl (3S)-3-acetyloxy-3-[(1R,2R,5R,6R,7R,8S,10S,11S,14S)-11-(furan-3-yl)-8-hydroxy-5-(2-hydroxypropan-2-yl)-2,6,10-trimethyl-3,13-dioxo-12,15-dioxatetracyclo[8.5.0.01,14.02,7]pentadecan-6-yl]propanoate
IUPAC Name ethyl (3S)-3-acetyloxy-3-[(1R,2R,5R,6R,7R,8S,10S,11S,14S)-11-(furan-3-yl)-8-hydroxy-5-(2-hydroxypropan-2-yl)-2,6,10-trimethyl-3,13-dioxo-12,15-dioxatetracyclo[8.5.0.01,14.02,7]pentadecan-6-yl]propanoate
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier n.a.
PubChem CID 86302658
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000258] Steroids and steroid derivatives
        • [CHEMONTID:0001125] Steroid lactones

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey WOIPTRVZUMZNCI-ANNBEMHLSA-N
Standard InCHI InChI=1S/C30H40O11/c1-8-38-21(34)12-20(39-15(2)31)28(6)18(26(3,4)36)11-19(33)29(7)22(28)17(32)13-27(5)23(16-9-10-37-14-16)40-25(35)24-30(27,29)41-24/h9-10,14,17-18,20,22-24,32,36H,8,11-13H2,1-7H3/t17-,18-,20-,22+,23-,24+,27-,28+,29+,30+/m0/s1
SMILES CCOC(=O)C[C@@H]([C@]1([C@@H](CC(=O)[C@@]2([C@@H]1[C@H](C[C@@]3([C@]24[C@H](O4)C(=O)O[C@H]3C5=COC=C5)C)O)C)C(C)(C)O)C)OC(=O)C

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   576.26 Volume:   565.527
?
Van der Waals volume.
Dense:   1.019 LogP:   1.476
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   1.805
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -3.321
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   9.0 Rigid Bonds:   27.0
TPSA:   162.1
?
Topological Polar Surface Area.
H-Bond Acceptor:   11.0
H-Bond Donor:   2.0 Rings:   5.0
Heavy Atoms:   11.0

MedChem Properties

QED Drug-Likeness Score:   0.279 GASA:   1.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   5.921 Fsp3:   0.733
MCE-18:   181.346
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Accepted
Pfizer Rule:   Rejected GSK Rule:   Accepted
Golden Triangle Rule:   Accepted BMS Rule:   0
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.448 Fluc inhibitor:   0.001
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.008
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.03
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.05 Promiscuous compounds:   0.507

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -5.251 MDCK Permeability:   -4.799
Pgp-inhibitor:   0.378 Pgp-substrate:   0.013
PAMPA:   0.968
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.002
20% Bioavailability (F20%):   0.021 30% Bioavailability (F30%):   0.129
50% Bioavailability (F50%):   0.788

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.001 MRP1:   0.958
Plasma Protein Binding (PPB):   65.607% Volume Distribution (VD):   -0.359
Fu: 31.497%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.972
OATP1B3 inhibitor:   0.998 BCRP inhibitor:   0.122
BSEP inhibitor:   0.983

ADMET: Metabolism

CYP1A2-inhibitor:   0.203 CYP1A2-substrate:   0.004
CYP2C19-inhibitor:   0.559 CYP2C19-substrate:   0.006
CYP2C9-inhibitor:   0.015 CYP2C9-substrate:   0.0
CYP2D6-inhibitor:   0.0 CYP2D6-substrate:   0.041
CYP3A4-inhibitor:   0.668 CYP3A4-substrate:   0.634
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   0.672
HLM stability:   0.72
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  5.889 Half-life (T1/2):  1.094

ADMET: Toxicity

hERG Blockers:  0.046 hERG Blockers (10um):  0.334
Human Hepatotoxicity (H-HT):  0.408 Drug-induced Liver Injury (DILI):  0.545
AMES Toxicity:  0.438 Rat Oral Acute Toxicity:  0.791
Maximum Recommended Daily Dose:  0.897 Skin Sensitization:  0.774
Carcinogencity:  0.561 Eye Corrosion:  0.0
Eye Irritation:  0.392 Respiratory Toxicity:  0.916
Drug-induced Neurotoxicity:  0.171 Ototoxicity:  0.558
Hematotoxicity:  0.45 Drug-induced Nephrotoxicity:  0.777
Genotoxicity:  0.983 RPMI-8226 Immunitoxicity:  0.231
A549 Cytotoxicity:  0.002 Hek293 Cytotoxicity:  0.036
BCF:   0.419
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   3.171
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   5.075
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   4.462
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO33678 Clausena emarginata Species Rutaceae Eukaryota stems Xishuangbanna, Yunnan Province, China 2010-AUG PMID[24593150]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT393 Cell line HCT-116 Homo sapiens IC50 > 10000 nM PMID[24593150]
NPT65 Cell line HepG2 Homo sapiens IC50 > 10000 nM PMID[24593150]
NPT1820 Cell line NCI-H1650 Homo sapiens IC50 > 10000 nM PMID[24593150]
NPT146 Cell line SK-OV-3 Homo sapiens IC50 > 10000 nM PMID[24593150]
NPT2 Others Unspecified n.a. IC50 = 5100 nM PMID[24593150]
NPT2 Others Unspecified n.a. IC50 > 10000 nM PMID[24593150]

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC476858 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9067 High Similarity NPC476856
0.7654 Intermediate Similarity NPC476853
0.7195 Intermediate Similarity NPC476861
0.7195 Intermediate Similarity NPC476850
0.6867 Remote Similarity NPC476857
0.6023 Remote Similarity NPC237155
0.5843 Remote Similarity NPC23387
0.5843 Remote Similarity NPC305016
0.5761 Remote Similarity NPC25255
0.573 Remote Similarity NPC609366
0.5568 Remote Similarity NPC470939
0.5495 Remote Similarity NPC96443
0.5495 Remote Similarity NPC472653
0.5495 Remote Similarity NPC290400
0.5495 Remote Similarity NPC476860
0.5213 Remote Similarity NPC193798
0.5208 Remote Similarity NPC600547
0.5158 Remote Similarity NPC604177
0.5102 Remote Similarity NPC472651
0.5054 Remote Similarity NPC611370
0.5053 Remote Similarity NPC117986
0.505 Remote Similarity NPC472652

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC476858 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
NPD

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data